Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2022
- The Future of Generics
Advertise

Search

Search

Close

Trending

Vir awarded $1 billion multi-year BARDA influenza contract

GSK’s Jemperli/TIM-3 immuno-oncology combo moves to ph3

Digital health financing drops again, but don’t worry yet

Sanofi wagers $400m on miRecule muscular dystrophy therapy

Cutting the combination therapy access issue down to size

Cell Mogrify

Round-up-16x9-2

R&D/ R&D/ Views & Analysis/ Views and analysis

R&D Roundup: Pharma gets in on the biotech boom

George Underwood Alexion, Alnylam, Biotech, Cell Mogrify, Novartis, R&D, Roche, Spark Therapeutics, UK 0 Comment

Some good news for the UK industry in turbulent times is always welcome, and several announcement this month

X

R&D Roundup: Pharma gets in on the biotech boom

https://pharmaphorum.com/r-d/views-analysis-r-d/rd-roundup-pharma-gets-in-on-the-biotech-boom/

cancer_cells

News/ News/ R&D

Cell Mogrify gets £420k funding for regenerative cell therapies

George Underwood CAR T, Cell Mogrify, cell therapy, immuno-oncology, Mogrify, T-cells 0 Comment

UK cell therapy company Cell Mogrify has been awarded £420,000 funding from Innovate UK to accelerate its data-driven

X

Cell Mogrify gets £420k funding for regenerative cell therapies

https://pharmaphorum.com/news/cell-mogrify-gets-420k-funding-for-regenerative-cell-therapies/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

Amylyx ALS drug draws criticism over $158,000 price tag
Roche gets FDA approval for HER2 breast cancer diagnostic
Translarna not approved by NICE for DMD on NHS
AstraZeneca pays record 660% premium for gene editing company LogicBio
Novo Nordisk achieve headline results with icodec insulin

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com